← ANALYSTS · TIPRANKS
Boris Peaker · JonesTrading
Hits
49%
232 of 476 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+22.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
22
Buy / hold / sell: 20 / 2 / 0
Upside of the analyst’s targets
+187.8%
Average over 20 current targets, to the last price
The market’s answer to the ratings
+10.1%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 6on TipRanks 15:50 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $45.00 → $22.00−51.1% | +32.1% | −47.5%next day +12.2% · 5 days +6.8% | ↗ |
| Sep 27on TipRanks Sep 28 00:45 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $20.00 | +22.9% | +2.0%next day +4.0% · 5 days +8.4% | ↗ |
| Sep 14on TipRanks 09:15 | WHWKIWMWhitehawk Therapeutics · $173M | Reiterated | Buy | $7.00 | +142.2% | −0.5%next day +1.0% · 5 days −2.6% | ↗ |
| Sep 14on TipRanks 05:55 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $36.00 | +178.4% | −0.5%next day +1.1% · 5 days +2.7% | ↗ |
| Sep 10on TipRanks 07:50 | TYRAIWMTyra Bioscience · $1.3B | Reiterated | Buy | $56.00 | +202.4% | +7.6%next day −7.3% · 5 days +3.2% | ↗ |
| Sep 9on TipRanks 08:10 | BEAMIWMBeam Therapeutics · $2.6B | Reiterated | Buy | $35.00 | +49.1% | −5.7%next day −2.6% · 5 days −7.1% | ↗ |
| Sep 8on TipRanks 09:45 | BCAXIWMBicara Therapeutics Inc. · $1.2B | Reiterated | Buy | $30.00 | +78.8% | +2.9%next day +0.2% · 5 days −3.3% | ↗ |
| Aug 17on TipRanks 07:57 | ELTXIWMElicio Therapeutics · $48M | Reiterated | Hold | — | — | −1.8%next day +3.7% · 5 days −0.1% | ↗ |
| Aug 14on TipRanks 16:35 | ANLAdlai Nortye Ltd. Sponsored ADR · $701M | Reiterated | Buy | $22.00 | +99.5% | +1.2%next day +6.8% · 5 days +7.3% | ↗ |
| Aug 12on TipRanks 17:15 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $45.00 | +170.1% | −5.3%next day −1.4% · 5 days −0.8% | ↗ |
| Aug 12on TipRanks 17:15 | MNPRIWMMonopar Therapeutics Inc · $482M | Reiterated | Buy | $130 | +87.7% | −4.6%next day +2.6% · 5 days +2.4% | ↗ |
| Aug 11on TipRanks Aug 12 01:15 | TARAIWMProtara Therapeutics · $142M | Reiterated | Buy | $25.00 | +977.6% | −4.5%next day −0.8% · 5 days +2.2% | ↗ |
| Aug 7on TipRanks 07:45 | JANXIWMJanux Therapeutics Inc · $1.1B | Reiterated | Buy | $28.00 | +69.6% | −2.2%next day +3.6% · 5 days +1.3% | ↗ |
| Aug 6on TipRanks 19:55 | PRMEIWMPrime Medicine, Inc. · $655M | Reiterated | Buy | $5.00 | +44.1% | +3.8%next day +2.3% · 5 days −0.1% | ↗ |
| Aug 6on TipRanks 18:46 | NUVBIWMNuvation Bio · $1.7B | Reiterated | Buy | $12.00 | +169.7% | +7.4%next day 0.0% · 5 days −6.2% | ↗ |
| Aug 6on TipRanks 17:31 | CGONIWMCG Oncology, Inc. · $5.5B | Reiterated | Buy | $85.00 | +42.0% | −0.3%next day +2.0% · 5 days −0.5% | ↗ |
| Aug 6on TipRanks 09:10 | ELVNIWMEnliven Therapeutics · $2.9B | Reiterated | Buy | $70.00 | +87.6% | +1.1%next day −0.3% · 5 days −4.9% | ↗ |
| Aug 6on TipRanks 08:50 | CNTXIWMContext Therapeutics · $22M | Reiterated | Buy | $7.00 → $2.00−71.4% | +719.7% | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Aug 5on TipRanks 21:06 | EDITIWMEditas Medicine · $375M | Reiterated | Buy | $8.00 | +240.4% | +5.6%next day −1.3% · 5 days −4.3% | ↗ |
| Aug 5on TipRanks 07:30 | OKURIWMOnKure Therapeutics · $91M | Reiterated | Hold | — | — | +1.7%next day −0.1% · 5 days −5.9% | ↗ |
| Aug 4on TipRanks 08:16 | FTHFaeth Therapeutics · $517M | Initiated | Buy | $55.00 | +192.6% | −8.5%next day −3.4% · 5 days +17.7% | ↗ |
| Aug 4on TipRanks 07:56 | ORICIWMOric Pharmaceuticals · $1.3B | Reiterated | Buy | $25.00 | +102.4% | +25.3%next day −3.8% · 5 days +2.0% | ↗ |
| Feb 13on TipRanks 10:00 | ALTIWMAltimmune · $459M | Initiated | Buy | $7.00 | +218.2% | −0.9%next day −0.8% · 5 days −0.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗